Seel,

Once we have established MTD for Kevetrin, how long will most clinical trials take that combine K with another already approved FDA drug?  Do they have to go thru a full Phase I or can they combine dosages of each approved ingredient at the safe level so that they essentially are starting out with a Phase II trial right at the efficacy dosage level from the get go?

Do you see any way if we get MTD for K by the end of the year that some of these combo drugs could be in and complete trials next year?

TIA

Pete